ARTICLE | Company News
Ciphergen other research news
August 23, 2004 7:00 AM UTC
Researchers published in Cancer Research that a pattern of 3 biomarkers detected stage I/II ovarian cancer with 74% sensitivity at 97% specificity in serum samples from 503 women with ovarian cancer, ...